The veterinary point of care (PoC) market will experience robust expansion between 2025 and 2035 because veterinarians are increasing their pet ownership numbers while expanding their appreciation for animal health and demanding faster diagnostic results for clinical and field settings.
The ability to conduct rapid diagnostics through point of care testing at veterinary consultations enhances veterinary decision-making abilities and produces better results for treating small animals as well as livestock and exotic species. By 2035 the point of care testing market will reach USD 4,458.5 million through predicted annual growth of 8.4% starting from its 2025 value at USD 1,990.2 million.
The veterinary sector undergoes transformation through technological developments of portable analyzers combined with immunoassays and molecular diagnostics and biosensors which provide both rapid and accurate testing methods that maintain minimal patient invasiveness.
Preventive veterinary care along with wellness screening practices have increased the adoption of point-of-care solutions which include infectious disease detection and perform tests on blood analysis, biochemistry and parasitology.
Tele-veterinary services together with mobile clinics have generated increased demand for simple and portable diagnostic systems. Veterinary practices which deliver efficient client-centered services embrace rising investment levels in point of care technologies for both small and large animal health sectors.
Key Market Metrics
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 1,990.2 million |
| Industry Value (2035F) | USD 4,458.5 million |
| CAGR (2025 to 2035) | 8.4% |
North America is leading the veterinary point-of-care market, mainly due to a flourishing pet care industry, high expenditure for veterinary healthcare, and early acceptance of the real-time diagnostics. The USA and Canada are witnessing increasing incorporation of Point of Care devices in veterinary hospitals, specialty clinics, and mobile practices for holistic animal health management.
The constant growth in Europe is also reinforced by preventive veterinary health care and livestock health monitoring. Point of care testing is already seeing uptake in Germany, the UK and France for increased diagnosis capabilities in companion animal and agricultural sectors, buoyed up with vibrant veterinary infrastructure.
Asia-pacific is emerging as a high-growth region due to several dominant features, including an increasing rate of pet categorization, increased awareness of zoonotic disease, and broadening veterinary health care infrastructure. Countries, such as China, India, Japan, and Australia, have developed their PoC veterinary solutions for the urban pet care market and rural livestock husbandry initiatives.
Cost Constraints and Limited Diagnostic Standardization
The veterinary point-of-care market finds itself grappling with high costs associated with diagnostic equipment and lack of standardized protocols across species. Many veterinary clinics, especially in rural and small-scale practices, find it tough to justify the investments in rapid analyzers and handhelds because of a relatively low patient turnover.
When different animal types develop the same disease with markedly different presentations, assay sensitivity and specificity become further confused. Inconsistent regulatory scrutiny for veterinary devices as compared to that of human diagnostics may curb innovation but also leads to inconsistent test reliability across manufacturers, consequently causing a dent in the confidence of practitioners and the quality of veterinary care.
Rising Pet Ownership, Livestock Monitoring, and Rapid Diagnostics Adoption
The veterinary POC market is rapidly expanding despite its cost and variability challenges as an increase in demand for fast and accurate diagnostics for companion animal care and livestock management rises. Recent trends for the humanization of pets are leading to investments in premium care, including blood tests in the clinic, urinalysis, and infectious disease screening.
In big animals, portable analyzers keep veterinarians abreast of herd health management, especially in remote settings. New advances in portable biochemistry, immunoassay platforms, and AI-enabled imaging tools facilitate rapid and accurate diagnosis. With the growing focus on preventive veterinary care globally, POC technologies are preparing clinics for fast turnaround decision-making and better health outcomes.
Companion animal clinics saw tremendous growth between 2020 and 2024, with an emphasis on rapid blood chemistry analyzers, tests for infectious diseases, and imaging devices such as portable ultrasound systems.
From 2025 to 2035, the market is expected to tilt toward AI-enabled diagnostics, animal health trackers for wearables, and cloud-based POC platforms. The combination of telemedicine, remote herd monitoring, and personalized pet wellness programs will therefore open up demand for seamless, real-time veterinary diagnostics in urban and rural areas.
Market Shifts: Comparative Analysis (2020 to 2024 vs. 2025 to 2035)
| Market Factor | 2020 to 2024 |
|---|---|
| Regulatory Landscape | Basic approval processes with limited global harmonization. |
| Technological Advancements | Use of rapid blood analyzers, handheld imaging, and infectious disease tests. |
| Sustainability Trends | Focused on single-use cartridges and portable device recyclability. |
| Market Competition | Led by veterinary diagnostic equipment manufacturers and animal health companies. |
| Industry Adoption | Common in veterinary clinics, equine centers, and mobile practices. |
| Consumer Preferences | Focused on rapid, affordable diagnostics at the clinic. |
| Market Growth Drivers | Boosted by pet population growth and livestock health management needs. |
| Market Factor | 2025 to 2035 |
|---|---|
| Regulatory Landscape | Expansion into AI-supported veterinary diagnostic certification and global standardization. |
| Technological Advancements | Growth in multi-parameter devices, wearable trackers, and smart data-driven diagnostic systems. |
| Sustainability Trends | Surge in sustainable veterinary consumables, rechargeable devices, and eco-conscious packaging. |
| Market Competition | Entry of digital veterinary care platforms, AI diagnostic startups, and smart farm tech firms. |
| Industry Adoption | Expands to remote livestock operations, tele-veterinary services, and personalized pet care models. |
| Consumer Preferences | Shift to integrated wellness monitoring, home testing kits, and real-time remote veterinary consultations. |
| Market Growth Drivers | Accelerated by preventive veterinary care trends, wearable tech innovation, and digital health integration. |
With high pet adoption rates, vigorous investment in animal healthcare, and an increase in demand for rapid diagnostics at veterinary clinics, the veterinary point of care market in the United States is witnessing steady growth.
Hand-held blood analyzers, rapid infectious disease test kits, and mobile imaging devices are gaining preference in USA veterinary practices to deliver immediate diagnostic results for companion animals as well as livestock. The increasing integration of point-of-care data into veterinary practice management software further gives an impetus to the market.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 8.2% |
Growth in the UK is being supported by increased veterinary visits toward companion animals, and the NHS's influence on advancing digital health models into veterinary services.
Portable veterinary instruments for hematology, biochemistry, and infectious disease testing are now being adopted by UK veterinary clinics and rural practices to allow faster treatment decisions that ultimately translate into better welfare outcomes for animals.
| Country | CAGR (2025 to 2035) |
|---|---|
| UK | 8.1% |
The EU represents a strong and innovation-driven market for veterinary point-of-care, especially Germany, France, and the Netherlands.
Fast adoption of small diagnostic devices by veterinary practices within the EU for well-being screening, orthopedic injury evaluation, and herd health monitoring in livestock farming is evident. Equally, the regulatory support for animal health and traceability initiatives is creating a pull for acceptance of mobile diagnostic platforms across the farm veterinary landscape.
| Region | CAGR (2025 to 2035) |
|---|---|
| European Union | 8.4% |
Japan's veterinary point-of-care market is growing steadily with the presence of a large aging population of companion animals and furthermore accented by an increasing demand for immediate diagnostic insights during clinic visits.
To handle chronic kidney failure and infectious diseases more efficiently, Japanese clinics are implementing compact chemistry analyzers, ultrasound systems, and multiplex test kits.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 8.0% |
With urbanization, increasing pet insurance coverage, and growing demand for advanced pet care services, the veterinary point-of-care market in South Korea grows strongly.
South Korean chains and independent clinics are implementing AI-assisted imaging devices, mobile laboratory equipment, and wireless diagnostics for enhanced diagnostic speed, clinical outcomes, and customer satisfaction.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 8.7% |
The continuing increase in pet ownership, money spent in animal health care, and the faster, more on-site demand for diagnostic solutions have contributed to steady growth in the veterinary point-of-care market. Point-of-care devices enable early diagnosis and treatment of pets by eliminating time delays involved in transporting samples to laboratories outside the practice for analysis.
Most of the products available, including consumables, reagents, and kits, lead in the market because of indispensable use in almost all routine diagnostics and disease monitoring in veterinary medicine. Companion animals lead by type of animal under consideration, with pet owners looking for preventive care and fast diagnosis and better treatment outcomes for their pets.
Diagnosis orienting towards the client and early disease mitigation will define the future in the veterinary practice; hence, these two segments remain very alive in underlining the future of point of care testing in animal health.
| Product Type | Market Share (2025) |
|---|---|
| Consumables, Reagents & Kits | 47.9% |
The product type segment of point-of-care veterinary diagnostics comprises consumables, reagents, and kits, which form the backbone of routine diagnostic and therapeutic monitoring applications. They are used to diagnose infections, metabolic disorders, or organ pathology by the veterinarian on-site from an available array of blood chemistry panels, immunoassay test kits, and microbiological reagents.
These allow faster decision-making with immediate treatment initiation, leading to improved patient outcomes. Very much spoiled by choice, clinicians use these consumables for real-time blood testing, fecal diagnostics, urinalysis, and detection of infectious diseases amid the hustle and bustle of daily practice.
Manufacturers emphasis on making single-use cartridges, portable assay panels, or simple and speedy immune chromatographic tests that enhance clinical performance on-stand, mobile units, commonly referred to as veterinary offices on wheels, and even fieldwork.
Along with that, further integration with point-of-care analyzers for data capture and record-keeping is the current focus of companies developing consumable-based tests. With increasing importance attached to preventive healthcare, chronic disease management, and cost-effectiveness, consumables, reagents, and kits will be the most important element in driving daily veterinary diagnostics across global animal health markets.
| Animal Type | Market Share (2025) |
|---|---|
| Companion Animals | 54.6% |
Companion animals hold the leading position in veterinary point-of-care testing markets because pet populations are growing worldwide alongside human treatment for pets and enhanced pet medical care investments.
Veterinarians conduct regular wellness screenings and preventive diagnostic examinations for dogs as well as cats and exotic pets since prompt diagnostic testing at the veterinary clinic is beneficial for these extended patient populations. The expectations of quick health evaluations for pets drives veterinarians to prioritize blood tests and infection tests as well as imaging assessments at veterinary offices.
The diagnosis of diabetes and renal disease and parvovirus infections and hypothyroidism requires veterinarians to use point of care technologies for companion animals. These diagnostic devices simultaneously hasten clinical work while improving both patient results and owner satisfaction.
Manufacturers invest in designing smaller medical devices for companion animals whose body systems match each device while this activity sustains market expansion. The growing global interest in animal healthcare combined with preventive wellness plans will sustain companion animals as the market's main force for growth in the veterinary point of care sector.
The veterinary point of care (POC) market serves as a vital and rapidly expanding animal health diagnostics segment which enables real-time testing solutions for disease examination and wellness checks and emergency diagnostics for companion animals together with livestock and equines.
The veterinary POC technology consists of portable blood analyzers, immunodiagnostic kits, molecular testing platforms and imaging systems and multiparameter monitoring devices. The market expands due to increasing pet adoption along with rising demand for early disease diagnosis as well as expanded livestock health programs and the necessity of decentralized and instantaneous field diagnostics.
Companies in the market build their competitive advantage through short assay responses combined with portable devices along with precise diagnostics and universal testing capacity and seamless connection to veterinary practice operational systems.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| IDEXX Laboratories, Inc. | 30-34% |
| Zoetis Inc. | 22-26% |
| Heska Corporation (Mars Inc.) | 14-18% |
| Thermo Fisher Scientific Inc. ( VetMed ) | 9-13% |
| Virbac S.A. | 6-10% |
| Other Companies (combined) | 15-20% |
| Company Name | Key Offerings/Activities |
|---|---|
| IDEXX Laboratories | Markets Catalyst One® chemistry analyzers, SNAP® immunoassay tests, and SediVue ® Dx urine sediment analyzers for in-clinic, real-time veterinary diagnostics in 2025. |
| Zoetis Inc. | Provides the Vetscan ® suite including VS2 chemistry analyzer, HM5 hematology system, and VUE rapid test platform for companion animal diagnostics in 2024. |
| Heska Corporation | Offers Element DC®, Element HT5™, and Element POC blood analyzers focused on veterinary-specific lab-quality results for in-clinic use in 2025. |
| Thermo Fisher Scientific | Expands VetMed portfolio with PCRVet ™ molecular diagnostics and portable diagnostic kits for infectious disease surveillance and field testing in 2024. |
| Virbac S.A. | Supplies rapid diagnostic tests for canine and feline infectious diseases and wellness panels, particularly in Europe, Latin America, and Asia-Pacific in 2025. |
Key Company Insights
IDEXX Laboratories, Inc.
IDEXX leads the veterinary POC market with a comprehensive suite of diagnostic instruments and test kits covering blood chemistry, hematology, urinalysis, infectious disease detection, and cancer screening. Its SNAP® platform is a gold standard for rapid immunoassays in veterinary clinics.
Zoetis Inc.
Zoetis has significantly expanded its presence in veterinary POC through its Vetscan® brand, offering portable chemistry, hematology, and molecular diagnostics solutions optimized for speed, accuracy, and small clinic settings.
Heska Corporation (Mars Inc.)
Heska focuses on high-quality, compact diagnostic analyzers that deliver fast, lab-grade results at the point of care. Its Element™ series supports companion animal practices and emergency veterinary services.
Thermo Fisher Scientific Inc. (VetMed)
Thermo Fisher’s VetMed segment provides specialized PCR and immunoassay solutions for zoonotic and endemic animal diseases. Its portable PCRVet™ systems enable veterinarians to conduct field-based diagnostics efficiently.
Virbac S.A.
Virbac offers cost-effective, easy-to-use veterinary rapid tests tailored to companion animals and livestock, focusing on accessibility in emerging veterinary markets and supporting disease control programs.
Other Key Players (15 to 20% Combined)
Several emerging diagnostics companies, technology startups, and regional suppliers contribute to the veterinary POC market through innovative platforms, portable lab systems, and specialized testing services:
The overall market size for the veterinary point of care market was USD 1,990.2 million in 2025.
The veterinary point of care market is expected to reach USD 4,458.5 million in 2035.
The increasing pet ownership rates, rising demand for rapid diagnostic solutions, and growing use of consumables in companion animal testing fuel the veterinary point of care market during the forecast period.
The top 5 countries driving the development of the veterinary point of care market are the USA, UK, European Union, Japan, and South Korea.
Consumables and companion animal testing lead market growth to command a significant share over the assessment period.
Explore Animal Health Devices Insights
Veterinary Point of Care Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
